SCHEMBL3671560

SCHEMBL3671560

Cc1cccc(C)c1OCC1CO1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.65
GLA P06280 1/20 0.65
TSHR P16473 4/20 0.58
TP53 P04637 3/20 0.58
CYP3A4 P08684 3/20 0.58
HIF1A Q16665 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
TDP1 Q9NUW8 1/20 0.55
CYP1A2 P05177 3/20 0.47
MAPT P10636 2/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PPARG P37231 1/20 0.47
SCN4A P35499 7/20 0.44
LMNA P02545 3/20 0.44
SCN1A P35498 2/20 0.44
SCN5A Q14524 2/20 0.44
SCN9A Q15858 2/20 0.44
CYP2D6 P10635 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL731211 0.89 ALDH1A1 (0.72) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL11590835 0.88 ALDH1A1 (0.56) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL18680125 0.88 ALDH1A1 (0.56) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL13384804 0.86 ALDH1A1 (0.54) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL9410285 0.85 ALDH1A1 (0.53) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL12130834 0.82 ALDH1A1 (0.53) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL1673418 0.82 ALDH1A1 (0.67) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL9356930 0.81 ALDH1A1 (0.49) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL18722962 0.81 ALDH1A1 (0.49) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL6206644 0.81 ALDH1A1 (0.49) ALDH1A1GLATSHRTP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7049388-B2 Process for manufacturing an α-dihydroxy derivative and epoxy resins prepared therefrom DOW GLOBAL TECHNOLOGIES INC. (US) 2006-05-23 US claimed
EP-1080084-B1 PROCESS FOR EPOXIDATION OF ARYL ALLYL ETHERS DOW GLOBAL TECHNOLOGIES INC (US) 2004-05-06 EP claimed
US-6646102-B2 Epoxidizing an alpha - halohydrin intermediate produced from a halide substitution of an alpha -dihydroxy derivative which has been obtained by a dihydroxylation reaction of an aryl allyl ether, oxidation catalysts DOW GLOBAL TECHNOLOGIES INC. 2003-11-11 US claimed
US-20030105268-A1 Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom DOW GLOBAL TECHNOLOGIES INC. 2003-06-05 US claimed
JP-2002517387-A 2002-06-18 JP claimed
CN-1303382-A Epoxidation process for aryl allyl ethers DOW CHEMICAL CO (US) 2001-07-11 CN claimed
EP-1080084-A2 PROCESS FOR EPOXIDATION OF ARYL ALLYL ETHERS THE DOW CHEMICAL COMPANY (US) 2001-03-07 EP claimed
US-6087513-A REACTION OF ALLYL ARYL ETHER WITH HYDROGEN PEROXIDE IN THE PRESENCE OF TRANSITION METALS FOR OXIDATION THE DOW CHEMICAL COMPANY (US) 2000-07-11 US claimed
WO-1999062894-A2 PROCESS FOR EPOXIDATION OF ARYL ALLYL ETHERS THE DOW CHEMICAL COMPANY (US) 1999-12-09 WO claimed
WO-2021059419-A1 PHOTOCURABLE RESIN COMPOSITION FOR ELECTRONIC DEVICES 積水化学工業株式会社 2021-04-01 WO disclosed
US-10435382-B2 Epoxy compound, epoxy resin, curable composition, cured product thereof, semiconductor sealing material, and printed circuit board DIC CORPORATION (JP) 2019-10-08 US disclosed
US-20160130243-A1 EPOXY COMPOUND, EPOXY RESIN, CURABLE COMPOSITION, CURED PRODUCT THEREOF, SEMICONDUCTOR SEALING MATERIAL, AND PRINTED CIRCUIT BOARD DIC CORPORATION (JP) 2016-05-12 US disclosed
CN-102596557-B Heat-insulating molded part and method for producing same BERGHAMMER SIEGFRIED (AT) 2015-11-25 CN disclosed
US-9018281-B2 Set of resin compositions for preparing system-in-package type semiconductor device SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-04-28 US disclosed
US-5010198-A Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents JANSSEN PHARMACEUTICA N.V. (BE) 1991-04-23 US disclosed
EP-0184257-B1 BENZOXAZOL- AND BENZOTHIAZOLAMINE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1990-07-25 EP disclosed
US-4861785-A Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents JANSSEN PHARMACEUTICA N.V. (BE) 1989-08-29 US disclosed
US-4677170-A Polyepoxides and the use thereof CIBA-GEIGY CORPORATON (US) 1987-06-30 US disclosed
EP-0184257-A1 Benzoxazol- and benzothiazolamine derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1986-06-11 EP disclosed
US-4110472-A CEREBROVASCULAR INSUFFICIENCY, PSYCHOSTIMULATION BAYER AKTIENGESELLSCHAFT (DE) 1978-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130243-A1 EPOXY COMPOUND, EPOXY RESIN, CURABLE COMPOSITION, CURED PRODUCT THEREOF, SEMICONDUCTOR SEALING MATERIAL, AND PRINTED CIRCUIT BOARD RER1, ASH2L, PTGER1 ALDH1A1 505/4885GLA 2231/4885TSHR 4400/4885
US-10435382-B2 Epoxy compound, epoxy resin, curable composition, cured product thereof, semiconductor sealing material, and printed circuit board RER1, ASH2L, PTGER1 ALDH1A1 505/4885GLA 2231/4885TSHR 4400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.